Overview

Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05

Status:
Completed
Trial end date:
2017-08-28
Target enrollment:
Participant gender:
Summary
This study will evaluate longitudinal change of tau deposition as measured by flortaucipir F 18 uptake over time.
Phase:
Phase 2
Details
Lead Sponsor:
Avid Radiopharmaceuticals